Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1627 1639 1654 1658 1676
This examiner grants 59% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18265523 | SCG2 NEUROPEPTIDES AND USES THEREOF | Non-Final OA | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 17768537 | Bi-Peptide with Affinity to Extracellular Matrix Proteins or Cells and to Growth Factors for Tissue Healing and Regeneration | Non-Final OA | Mayo Foundation for Medical Education and Research |
| 17296795 | PEPTIDE LIGANDS FOR CAPTURE OF HOST CELL PROTEINS | Non-Final OA | North Carolina State University |
| 17292265 | SELF-ASSEMBLING VEGF NANOPARTICLES | Non-Final OA | Northwestern University |
| 18140681 | POLYMERIC CONJUGATES AND USES THEREOF | Final Rejection | Ramot at Tel-Aviv University Ltd. |
| 17778306 | POLYPEPTIDE INHIBITORS OF NEUTROPHIL ELASTASE ACTIVITY AND USES THEREOF | Final Rejection | The Regents of the University of Michigan |
| 17433009 | CARBAMOYL PHOSPHATE SYNTHATASE-1 FOR THE TREATMENT AND PREVENTION OF LIVER INJURY | Non-Final OA | The Regents of the University of Michigan |
| 18464285 | PEPTIDE KINASE INHIBITORS AND METHODS OF USE THEREOF | Non-Final OA | B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD. |
| 18037098 | VIBRIO TOXIN BINDING PROTEINS IN SHRIMP AND USES THEREOF | Non-Final OA | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA |
| 18872790 | PREVENTING ALU SINES-MEDIATED PATHOLOGIES | Final Rejection | UNIVERSITY OF SOUTH FLORIDA |
| 18265883 | METHODS OF MAKING WATER-SOLUBLE PROTEIN FORMED IN A BACTERIAL EXPRESSION SYSTEM, COMPOSITIONS, AND METHODS OF USE THEREOF | Non-Final OA | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK |
| 18037372 | HYDROXYSTEARIC ACID FOR INDUCING GENERATION OF ANTIMICROBIAL PEPTIDES | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 17279807 | INJECTABLE COMPOSITION | Non-Final OA | Sumitomo Pharma Co., Ltd. |
| 17396304 | Growth Hormone-Releasing Hormone Antagonists and Uses Thereof | Non-Final OA | University of Miami |
| 17781571 | PEPTIDES AND THEIR USE IN THE TREATMENT OF INFLAMMATION | Non-Final OA | ENLITISA (SHANGHAI) PHARMACEUTICAL CO., LTD. |
| 18439838 | FUNTIONALLY MODIFIED POLYPEPTIDES AND RADIOBIOSYNTHESIS | Non-Final OA | IKARIA INC. |
| 18426877 | Treatment of Homologous Recombination Deficient Cancers | Final Rejection | Sinai Health System |
| 17169835 | SEPARATION OF VWF AND VWF PROPEPTIDE BY CHROMATOGRAPHIC METHODS | Non-Final OA | Takeda Pharmaceutical Company Limited |
| 18067991 | NITRIC OXIDE HYDROGEL FOR PROMOTING TUMOR VASCULAR NORMALIZATION AND RADIOSENSITIZATION AND PREPARATION METHOD THEREOF | Non-Final OA | Nankai University |
| 17989817 | TARGETING G3BP AGGREGATION TO PREVENT NEURODEGENERATION | Non-Final OA | Tel HaShomer Medical Research Infrastructure and Services Ltd. |
| 18236085 | USE OF GOJI GLYCOPEPTIDE IN PREPARATION OF DRUG FOR PREVENTING AND/OR TREATING AMYOTROPHIC LATERAL SCLEROSIS | Non-Final OA | NINGXIA QIPEPTIDE TECHNOLOGY CO., LTD |
| 18273336 | INTRANASAL FORMULATIONS AND DELIVERY OF SOMATOSTATIN MIMETICS AND USES THEREOF | Non-Final OA | NBO PHARMA INC. |
| 18271353 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NK CELLS | Non-Final OA | BicycleTx Limited |
| 17610844 | COMPOSITION FOR PREVENTING OR TREATING NEUROTROPHIC KERATITIS WHICH CONTAINS PACAP PEPTIDE OR STABILIZED PACAP PEPTIDE | Non-Final OA | SENJU PHARMACEUTICAL CO., LTD. |
| 18044668 | BISPECIFIC FUSION POLYPEPTIDE COMPOUND | Non-Final OA | SHAANXI MICOT PHARMACEUTICAL TECHNOLOGY CO., LTD. |
| 18017669 | USE OF PERLECAN AND FRAGMENTS THEREOF TO REDUCE THE RISK OF DEATH IN STROKE PATIENTS | Non-Final OA | STREAM BIOMEDICAL, INC. |
| 17787979 | A COMPOSITION COMPRISING S-ARRESTIN PEPTIDES | Final Rejection | WORG PHARMACEUTICALS (ZHEJIANG) CO., LTD. |
| 17757402 | RETRO-INVERSO PEPTIDES | Non-Final OA | Herantis Pharma OYJ |
| 17757350 | TREATMENT OF ACUTE HEART FAILURE | Non-Final OA | AnaCardio R&D AB |
| 17781653 | SORTILIN BINDING CONJUGATE COMPOUNDS, COMPOSITIONS AND USES THEREOF FOR TREATING CANCER | Final Rejection | THERATECHNOLOGIES INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy